Poolbeg Pharma (LON:POLB) Reaches New 12-Month Low – Here’s What Happened

Poolbeg Pharma PLC (LON:POLB)’s stock price reached a new 52-week low during trading on Monday . The stock traded as low as GBX 2.25 ($0.03) and last traded at GBX 2.40 ($0.03), with a volume of 535255 shares. The stock had previously closed at GBX 2.43 ($0.03).

Analysts Set New Price Targets

Separately, Shore Capital restated a “house stock” rating on shares of Poolbeg Pharma in a report on Thursday, January 2nd.

Poolbeg Pharma Stock Performance

The stock has a 50-day moving average of GBX 3.74 and a two-hundred day moving average of GBX 6.10. The company has a market cap of £12.34 million, a P/E ratio of 0.00 and a beta of 2.11.

About Poolbeg Pharma

Poolbeg Pharma plc is a clinical-stage biopharmaceutical company focussed on the development of innovative medicines to address unmet medical needs. Poolbeg comprises a strong and growing portfolio of development assets.